Volume 13

  • No. 5 December 2019
    In this issue...

    • A review of the biopharma deals of 2019

    • Partnering with the complement cascade

  • No. 4 November 2019
    In this issue...

    • The art of closing a biopharma deal

    • Targeting common viral denominators to fight flu

  • No. 3 September 2019
    In this issue...

    • Monoclonal antibodies: competition increases for the top spot

    • Negotiating your biopharma deal term sheet

    • The biggest year yet for dealmaking in immuno-oncology

  • No. 2 June 2019
    In this issue...

    • The partnering landscape for CNS disorders

    • The rise of the cell and gene therapy market

    • Charting a year of biopharma dealmaking trends

    • The medtech industry: financing and deals review

  • No. 1 March 2019
    In this issue...

    • What are the recent dealmaking trends in oncology?

    • Milestone payments in biopharma deals